Supreme Court’s KSR Decision Should Not Worry Drug Industry - Mossinghoff
Executive Summary
The U.S. Supreme Court's recent ruling on patent obviousness will have little impact on the pharmaceutical and biotech industries, Gerald Mossinghoff, a former head of the Pharmaceutical Research and Manufacturers of America, predicts